The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma

SIMPLE SUMMARY: The introduction of monoclonal antibodies (moAbs) has dramatically improved outcomes in multiple myeloma (MM). Their high clinical efficacy and safe adverse risk profile have made moAbs a first choice in relapsed MM and have led to the introduction of moAbs into the standard upfront...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Meera, Maatman, Theresa Camille, Schinke, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507719/
https://www.ncbi.nlm.nih.gov/pubmed/34638393
http://dx.doi.org/10.3390/cancers13194909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507719/
https://www.ncbi.nlm.nih.gov/pubmed/34638393
http://dx.doi.org/10.3390/cancers13194909

Ejemplares similares